Skip to main content
. Author manuscript; available in PMC: 2011 May 19.
Published in final edited form as: Bioconjug Chem. 2010 May 19;21(5):828–835. doi: 10.1021/bc9005317

Figure 4.

Figure 4

A visible increase in signal intensity was seen in rat Ward Colon tumors (arrow) from pre-injection (left) to post-injection (right, 24 hrs post-injection) of conjugate 1 (HPPH-3Gd) at 10 μmol/kg (A) and at 5 μmol/kg (B). Tumor contrast enhancement of HPPH-3Gd compares favorable to Gd-DTPA administered at 10 μmol/kg (C) at 24h postinjection.